ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA
Clinical trials for ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-of-its-Kind trial aims to tame blood cancer with triple punch
Disease control OngoingThis early-stage study is testing a new combination of three drugs—rituximab, lenalidomide, and ibrutinib—in adults with previously untreated follicular lymphoma, a type of blood cancer. The main goal is to find the safest and most effective doses of the two newer drugs (lenalido…
Matched conditions: ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Gentler radiation zaps eye lymphoma with fewer side effects
Disease control OngoingThis study is testing whether a very low dose of radiation aimed at the eye socket can effectively control slow-growing B-cell lymphomas that involve the eye area. It aims to see if this lower dose can work as well as standard treatments while causing fewer side effects. The tria…
Matched conditions: ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC